Five Prime Therapeutics, Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was USD 13.178 million compared to USD 14.874 million a year ago. Operating loss was USD 92.870 million compared to USD 141.938 million a year ago. Net loss was USD 84.328 million compared to USD 137.202 million a year ago. Basic loss per share from continuing operations was USD 2.29 compared to USD 3.92 a year ago.